Literature DB >> 7004956

Dantrolene sodium suspension in treatment of spastic cerebral palsy.

R L Joynt, J A Leonard.   

Abstract

A double-blind study was carried out on 20 children with spasticity secondary to cerebral palsy, in order to compare the effects of dantrolene sodium suspension and a placebo. The drug was found to be physiologically active in reducing the force of muscle contraction, but objective functional improvement, as measured by multiple performance tests, was irregular and probably not significant.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7004956     DOI： 10.1111/j.1469-8749.1980.tb03742.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN： 0012-1622            Impact factor:   5.449


  8 in total

Review 1.  Treatment of Disorders of Tone and Other Considerations in Pediatric Movement Disorders.

Authors:  Stephen R Deputy; Ann H Tilton
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

Review 2.  Dantrolene.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1984-01

Review 3.  Spasticity and drug therapy.

Authors:  E W Wuis
Journal:  Pharm Weekbl Sci       Date:  1987-10-16

Review 4.  Management of children with multiple sclerosis.

Authors:  E Ann Yeh
Journal:  Paediatr Drugs       Date:  2012-06-01       Impact factor: 3.022

Review 5.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

Review 6.  Therapeutic interventions for tone abnormalities in cerebral palsy.

Authors:  Ann H Tilton
Journal:  NeuroRx       Date:  2006-04

Review 7.  Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  M R Delgado; D Hirtz; M Aisen; S Ashwal; D L Fehlings; J McLaughlin; L A Morrison; M W Shrader; A Tilton; J Vargus-Adams
Journal:  Neurology       Date:  2010-01-26       Impact factor: 9.910

Review 8.  Oral Muscle Relaxants for the Treatment of Chronic Pain Associated with Cerebral Palsy.

Authors:  Jacki Peck; Ivan Urits; Joshua Crane; Alexandra McNally; Nazir Noor; Megha Patel; Amnon A Berger; Elyse M Cornett; Hisham Kassem; Alan D Kaye; Omar Viswanath
Journal:  Psychopharmacol Bull       Date:  2020-10-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.